More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings (+333.3% Growth)
- Ratings (3.8 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (5/10/16)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 340.35M
Short-term investments 0
Accounts receivable, net 324.45M
Inventory, net 125.58M
Deferred product manufacturing costs
Deferred income taxes
Prepaid expenses and other current assets 31.69M
Total current assets 822.07M
Property, plant and equipment, net 214.16M
Deferred product manufacturing costs
Deferred income taxes, net 315K
Other assets 73.76M
Goodwill 210.17M
Total assets 1.92B
Current liabilities:
Accounts payable 56.33M
Accrued expenses 204.71M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 65.73M
Deferred revenue 0
Total current liabilities 326.76M
Deferred revenue 0
Other liabilities 35.95M
Total liabilities 860.08M
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 729K
Additional paid-in capital 504.08M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -10.46M
Retained earnings 570.22M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 1.06B
Total liabilities and stockholders' equity 1.92B